FastTRACK (HyaloFAST) Trial for Repair of Articular Cartilage in the Knee

What we are studying

The purpose of this trial is to study a device called Hyalofast to see how safe it is and how well it works when combined with your own bone marrow cells (BMAC) in treating the damaged cartilage in your knee. The procedure using Hyalofast and BMAC is experimental in this study and will be compared to a commonly performed surgical procedure for cartilage repair called microfracture.

Who is Eligible

  • All Genders
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18 - 60

Eligibility Criteria

  • Further criteria will be discussed with study team.

What is involved

  • Informed Consent Review
  • Review of Medical History
  • Physical Examinations
  • Phone Calls and/or Emails
  • Study Visits and Consultations
  • Surveys/Questionnaires
  • Laboratory and Imaging Tests
  • Specimen Sample Collection
  • Diary/E-Diary Writing or Recordings
  • Use of Study Treatments or Placebo
  • Use of Study Health Plans
  • After Study Follow-Up Activities


Compensation will be discussed with the study team.

Contact Information

Study Coordinator
Preston Gammons
(336) 716-2060
Principal Investigator
Cristin Ferguson

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.